Authorized purpose: Concurrent-read CADe to identify and localize carious lesions on bitewing radiographs from adults at least 22 years old for board-licensed dentists; the device is an aid and does not replace dentist diagnosis.
Clinical role
Concurrent dental-image review through a Dental Viewer connected to a cloud API; the dentist uploads the bitewing image, reviews the binary finding and localized bounding boxes, and remains responsible for interpretation.
Images and patients
X-ray/Radiography · Teeth and tooth surfaces, including proximal, buccal/lingual, occlusal, root, and cervical surfaces
Key limitation
Keep in mind: Use is limited to board-licensed dentists, concurrent review of bitewing radiographs, and adult patients at least 22 years old. The output is an aid and does not replace dentist diagnosis or clinical judgment. Standalone performance was lower for the Schick 33 sensor than the full dataset, so sensor-specific generalizability must not be assumed from the overall result.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: Concurrent-read CADe to identify and localize carious lesions on bitewing radiographs from adults at least 22 years old for board-licensed dentists; the device is an aid and does not replace dentist diagnosis.
Which images or clinical context are in scope?Modality: X-ray/Radiography Anatomy or clinical context: Teeth and tooth surfaces, including proximal, buccal/lingual, occlusal, root, and cervical surfaces Input: Intraoral bitewing radiographs acquired from adult patients at least 22 years old; the standalone and reader studies used sensors including DEXIS Platinum, DEXIS Titanium, Gendex GXS-700, Kodak RVG 6100, RVG 5200, RVG 6200, and Schick 33.
Who uses it?Intended users: Board-licensed dentists
What does the software produce?Output: A binary indication of whether carious lesions were identified; when findings are present, coordinates of bounding boxes for each detected lesion; and, when no findings are present, a clear indication that no carious lesions were identified.
What is its most important limitation?Key limitation: Use is limited to board-licensed dentists, concurrent review of bitewing radiographs, and adult patients at least 22 years old. The output is an aid and does not replace dentist diagnosis or clinical judgment. Standalone performance was lower for the Schick 33 sensor than the full dataset, so sensor-specific generalizability must not be assumed from the overall result.
Clinical takeaway. Clinical role: Concurrent-read CADe to identify and localize carious lesions on bitewing radiographs from adults at least 22 years old for board-licensed dentists; the device is an aid and does not replace dentist diagnosis.
Evidence takeaway. Evidence from the reviewed source record: FDA standalone testing used 1,034 adult radiographs from 10 US sites, ground-truthed by three US board-certified dentists. The overall image-based AFROC Figure of Merit was 0.740 (95% CI 0.721-0.760), with image-based sensitivity 70.8% and PPV 59.5%; false-positive fraction was 0.335. Schick 33 had a lower standalone AFROC FOM of 0.608. The fully crossed randomized MRMC reader study used 226 adult radiographs from the same 10-site context and 21 readers; aided reader AFROC FOM was 0.739 versus 0.667 unaided, a difference of 0.072 (95% CI 0.047-0.097, p<0.0001).
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
Concurrent-read CADe to identify and localize carious lesions on bitewing radiographs from adults at least 22 years old for board-licensed dentists; the device is an aid and does not replace dentist diagnosis.
Concurrent dental-image review through a Dental Viewer connected to a cloud API; the dentist uploads the bitewing image, reviews the binary finding and localized bounding boxes, and remains responsible for interpretation.
Intraoral bitewing radiographs acquired from adult patients at least 22 years old; the standalone and reader studies used sensors including DEXIS Platinum, DEXIS Titanium, Gendex GXS-700, Kodak RVG 6100, RVG 5200, RVG 6200, and Schick 33.
A binary indication of whether carious lesions were identified; when findings are present, coordinates of bounding boxes for each detected lesion; and, when no findings are present, a clear indication that no carious lesions were identified.
Use is limited to board-licensed dentists, concurrent review of bitewing radiographs, and adult patients at least 22 years old. The output is an aid and does not replace dentist diagnosis or clinical judgment. Standalone performance was lower for the Schick 33 sensor than the full dataset, so sensor-specific generalizability must not be assumed from the overall result.
FDA standalone testing used 1,034 adult radiographs from 10 US sites, ground-truthed by three US board-certified dentists. The overall image-based AFROC Figure of Merit was 0.740 (95% CI 0.721-0.760), with image-based sensitivity 70.8% and PPV 59.5%; false-positive fraction was 0.335. Schick 33 had a lower standalone AFROC FOM of 0.608. The fully crossed randomized MRMC reader study used 226 adult radiographs from the same 10-site context and 21 readers; aided reader AFROC FOM was 0.739 versus 0.667 unaided, a difference of 0.072 (95% CI 0.047-0.097, p<0.0001).
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
FDA standalone testing used 1,034 adult radiographs from 10 US sites, ground-truthed by three US board-certified dentists. The overall image-based AFROC Figure of Merit was 0.740 (95% CI 0.721-0.760), with image-based sensitivity 70.8% and PPV 59.5%; false-positive fraction was 0.335. Schick 33 had a lower standalone AFROC FOM of 0.608. The fully crossed randomized MRMC reader study used 226 adult radiographs from the same 10-site context and 21 readers; aided reader AFROC FOM was 0.739 versus 0.667 unaided, a difference of 0.072 (95% CI 0.047-0.097, p<0.0001).
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
Videa Caries Assist regulatory performance study summary
DesignStand-alone performance and reader study (ACR AI Central category)
PopulationAdult
Scopeexact submission
Tested versionExact product version not reported; regulatory study summarized for FDA submission K213795
Samplen=1034
Sites10
IndependenceIndependence not established
K213795
ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K213795. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: Intraoral bitewing radiographs acquired from adult patients at least 22 years old; the standalone and reader studies used sensors including DEXIS Platinum, DEXIS Titanium, Gendex GXS-700, Kodak RVG 6100, RVG 5200, RVG 6200, and Schick 33.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: Videa Caries Assist is described as a cloud-based service available through an API behind a firewalled network; proper authentication and a Dental Viewer are required for upload and result review. The FDA packet does not establish DICOM, PACS, RIS, EHR, interface-version, or current commercial deployment compatibility.
Scope: Exact FDA submission.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Source context, not route validation: The exact FDA package describes a cloud-based software device available as a service via an API behind a firewalled network, accessed by the dental practitioner through their Dental Viewer to upload radiographs and review results. Current hosting, data flow, and commercial configuration require vendor confirmation.
Scope: Exact FDA submission. Packet wording: "Videa Caries Assist (VCA) software is a cloud-based AI-powered medical device for the automatic detection of carious lesions in dental radiographs." … "The device itself is available as a service via an API (Application Programming Interface) behind a firewalled network.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
Confirm processing location, queue ownership, exclusions and exact AI build.
Source context, not route validation: A binary indication of whether carious lesions were identified; when findings are present, coordinates of bounding boxes for each detected lesion; and, when no findings are present, a clear indication that no carious lesions were identified.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: A binary indication of whether carious lesions were identified; when findings are present, coordinates of bounding boxes for each detected lesion; and, when no findings are present, a clear indication that no carious lesions were identified.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
The exact FDA package describes a cloud-based software device available as a service via an API behind a firewalled network, accessed by the dental practitioner through their Dental Viewer to upload radiographs and review results. Current hosting, data flow, and commercial configuration require vendor confirmation.
Exact FDA submission
Checked 2026-11-14
Packet wording: "Videa Caries Assist (VCA) software is a cloud-based AI-powered medical device for the automatic detection of carious lesions in dental radiographs." … "The device itself is available as a service via an API (Application Programming Interface) behind a firewalled network.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
Videa Caries Assist is described as a cloud-based service available through an API behind a firewalled network; proper authentication and a Dental Viewer are required for upload and result review. The FDA packet does not establish DICOM, PACS, RIS, EHR, interface-version, or current commercial deployment compatibility.
ACR AI Central provides an exact-submission model card for Videa Caries Assist; FDA labeling remains controlling for clinical use, limitations, and performance.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Exact FDA record reviewedStatus
2026-09-20Last searched
23Fields reviewed
9Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not verified - checked 2026-09-08 - Exact FDA submission
No public price or quote for the exact K213795 configuration was established in this review.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Reimbursement: Not publicly available - checked 2026-09-08 - Exact FDA submission
No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Security: Not verified - checked 2026-09-08 - Exact FDA submission
Exact-release security controls, data retention, hosting boundaries, and scoped assurance documentation require vendor confirmation.
Installation timeline: Not yet reviewed
Training: Not verified - checked 2026-09-08 - Exact FDA submission
Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.
Monitoring: Not verified - checked 2026-09-08 - Exact FDA submission
Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.
Authorized purpose: Concurrent-read CADe to assist dentists in detecting specified tooth and jaw anatomy, bone-level landmarks, and root-canal-treated teeth in digital radiographs of permanent teeth in patients 15 years or older.
Modality
X-ray/Radiography
Anatomy
Permanent teeth and jaw/maxillofacial anatomy, including enamel, dentine, pulp, root, mental foramen, inferior alveolar canal, maxillary sinus, cementoenamel junction, crestal bone, and root-canal-treated teeth
Authorized purpose: Analyze frontal chest and abdominal X-ray images to detect and localize a nasally or orally inserted enteric tube, its tip and side port if present, and the diaphragm and airways for radiologist review.
Modality
X-ray/Radiography
Anatomy
Chest/lung and abdomen/stomach; enteric tube, tube tip and side port, diaphragm, and airways including carina and left/right bronchi
Authorized purpose: qXR-Detect is an adult chest-radiograph concurrent reading aid that identifies, highlights and categorizes suspicious regions of interest across lung, pleura, mediastinum/hila/heart, bone, hardware and other categories; trained clinicians remain responsible for primary interpretation.
Modality
X-ray/Radiography
Anatomy
Chest/Lung; pleura, mediastinum/hila/heart, bone, hardware and other chest-radiograph regions
Authorized purpose: Provides automated concurrent-read detection and segmentation of caries on bitewing radiographs in patients 18 and older, adding information for the dentist while requiring complete dentist review and judgment.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.